Atrial fibrillation is one of the most frequent heart rhythm disturbances found in clinical
practice. Anticoagulation, rate control, cardioversion, and ablative procedures have been the …

This article reviews current evidence of non‐antiarrhythmic agents for the prevention and
maintenance of sinus rhythm in patients with atrial fibrillation. These nontraditional agents …

Atrial fibrillation is the commonest sustained cardiac arrhythmia. It accounts for> 35% of all
hospital admissions for cardiac arrhythmias in the United States. The presence of atrial …

The inhibition of the renin‐angiotensin system has demonstrated both experimental and
clinical effects in preventing atrial fibrillation. However, there is still uncertainty about the role …

Atrial fibrillation (AF) is the most frequent arrhythmia found in clinical practice. The majority of
patients with AF are still candidates for antiarrhythmic drug treatment, not only for acute …

Antiarrhythmic Drugs for AF. Antiarrhythmic drugs have been used for the acute conversion
of atrial fibrillation to sinus rhythm, as well as for the long‐term maintenance of sinus rhythm …

Atrial fibrillation is the most commonly treated arrhythmia and its incidence is predicted to
increase. It is associated with significant morbidity and mortality. Preventive efforts should be …

Background Atrial fibrillation (AF), the most common form of sustained arrhythmia, is
associated with a frightening risk of embolic complications, tachycardia-related ventricular …

Atrial fibrillation (AF) is associated with a higher incidence of mortality, stroke, and coronary
events than is sinus rhythm. AF with a rapid ventricular rate may cause a tachycardia-related …

Enhanced understanding of the mechanisms underlying atrial fibrillation (AF) and advent of
catheter-based therapy for AF has altered the approach to patients with this most common …